Rigel Pharmaceuticals, Inc. - RIGL

About Gravity Analytica
Recent News
- 02.03.2026 - Rigel Appoints Michael P. Miller to the Board of Directors
- 02.03.2026 - Rigel Appoints Michael P. Miller to the Board of Directors
- 01.12.2026 - Rigel Provides Business Update and 2026 Outlook
- 01.12.2026 - Rigel Provides Business Update and 2026 Outlook
- 01.07.2026 - Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
- 01.07.2026 - Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
- 12.07.2025 - Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
- 12.07.2025 - Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
- 11.26.2025 - Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
- 11.26.2025 - Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
Recent Filings
- 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
- 02.03.2026 - 3 Initial statement of beneficial ownership of securities
- 02.03.2026 - 8-K Current report
- 01.12.2026 - 8-K Current report
- 01.12.2026 - EX-99.1 EX-99.1
- 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
- 12.10.2025 - EX-99.1 EX-99.1
- 12.10.2025 - 8-K Current report